JS Leeder
Impact in
- Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism
- Treatment of Major Depression
- Transplantation top 1%
- Renal Transplantation Outcomes and Treatments
Papers in
-
- Pharmacological Effects and Toxicity Studies 3
- Pharmaceutical studies and practices 3
- Prenatal Substance Exposure Effects 2
- Neonatal Health and Biochemistry 1
-
- Pharmacogenetics and Drug Metabolism 5
- Co-authors
- Andrea Gaedigk (5 shared papers)L. DiAnne Bradford (1 shared paper)R PEARCE (1 shared paper)Teri E. Klein (2 shared papers)Katrin Sangkuhl (1 shared paper)Yuan Ji (1 shared paper)Stuart A. Scott (1 shared paper)J K Hicks (1 shared paper)
- Journals
- Clinical Pharmacology & Therapeutics (8 papers)Pharmacoepidemiology and Drug Safety (1 paper)Clinical and Translational Science (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
JS Leeder
10 papers receiving 2.3k citations
JS Leeder's Hit Papers
Peers
Comparison fields: 5 of 89
- Pharmacology 1.3k
- Transplantation 317
- Pediatrics, Perinatology and Child Health 904
- Biological Psychiatry 73
- Pharmacology 386
Countries citing papers authored by JS Leeder
This map shows the geographic impact of JS Leeder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JS Leeder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JS Leeder more than expected).
Fields of papers citing papers by JS Leeder
This network shows the impact of papers produced by JS Leeder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JS Leeder. The network helps show where JS Leeder may publish in the future.
Co-authors
The 25 scholars most cited alongside JS Leeder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors Hit paper breakdown → | 2015 | 672 |
| 2 | The CYP2D6 Activity Score: Translating Genotype Information into a Qualitative Measure of Phenotype Hit paper breakdown → | 2007 | 587 |
| 3 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing Hit paper breakdown → | 2015 | 499 |
| 4 | 2008 | 183 | |
| 5 | 2008 | 121 | |
| 6 | 2016 | 113 | |
| 7 | 2009 | 63 | |
| 8 | 2015 | 51 | |
| 9 | 2015 | 17 | |
| 10 | 2016 | 10 |
About JS Leeder
JS Leeder is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology, Oncology, Pharmacology and Molecular Biology, having authored 10 papers that have together received 2.3k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (5 papers), Pharmacological Effects and Toxicity Studies (3 papers), Pharmaceutical studies and practices (3 papers), Prenatal Substance Exposure Effects (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Attention Deficit Hyperactivity Disorder (1 paper), Neonatal Health and Biochemistry (1 paper) and Calcium signaling and nucleotide metabolism (1 paper). The work is most often cited by research in Pharmacology (1.3k citations), Transplantation (317 citations), Pediatrics, Perinatology and Child Health (904 citations), Biological Psychiatry (73 citations) and Pharmacology (386 citations). JS Leeder has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Andrea Gaedigk, L. DiAnne Bradford, R PEARCE, Teri E. Klein, Katrin Sangkuhl, Yuan Ji, Stuart A. Scott, J K Hicks, Julia Stingl and Adrián LLerena. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Pharmacoepidemiology and Drug Safety and Clinical and Translational Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.